Burning Rock Biotech Limited (NASDAQ: BNR, “Burning Rock”) and Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad”) today announced a new global technology licensing agreement and strategic partnership to ...

On Jan. 10, 2025, one day after our son's first birthday, a genetic test gave us an answer we never expected. We learned our son has AUTS2 syndrome, a rare ...

All three kinesin transport families exhibit unexpectedly slow dissociation under load, explaining robust competition with dynein during bidirectional cargo transport.